Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Open-market sale Chief Legal Officer sold 15,000 shares at $18.90 ($283,496)
  2. 4 Open-market sale 10% owner sold 1,112,446 shares at an average $18.98 ($21,118,120)
  3. 4 Grant or award Chief Executive Officer acquired 26,667 shares (grant or award)
  4. 4 Open-market sale Director sold 1,900 shares at an average $20.21 ($38,406)
  5. 4 Open-market sale Director sold 1,707 shares at an average $20.21 ($34,498)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Other disposition 10% owner disposed of 2,614,157 shares (other)
  9. 4 Other disposition Director disposed of 2,614,157 shares (other)
  10. 4 Other disposition Director disposed of 2,614,157 shares (other)
  11. 4 Open-market sale Chief Executive Officer sold 18,470 shares at an average $20.76 ($383,393)
  12. 4 Open-market sale Chief Executive Officer sold 75,795 shares at an average $20.25 ($1,534,869)
  13. 4 Open-market sale Chief Business Officer sold 27,154 shares at an average $20.08 ($545,162)
  14. 4 Open-market sale Director sold 88,011 shares at $19.79 ($1,741,738)
  15. 4 Open-market sale Director sold 22,781 shares at an average $19.42 ($442,403)
  16. 4 Open-market sale Director sold 17,989 shares at $18.53 ($333,336)
  17. 4 Open-market sale Director sold 3,150 shares at an average $18.52 ($58,345)
  18. 4 Open-market sale Director sold 34,141 shares at an average $19.06 ($650,693)
  19. 4 Open-market sale Director sold 55,569 shares at an average $19.59 ($1,088,561)
  20. 4/A Insider Changes in Ownership

Page 21 of 26 · 502 filings